Published in Blood Weekly, December 21st, 2000
I. McNiece and colleagues associated with UC's Bone Marrow Transplantation Program noted that because a single unit of cord blood has relatively few cells, allogeneic cord blood (CB) products have been used to boost cellular support primarily in small children undergoing high-dose chemotherapy.
Additionally, they said, a median of 26 days was necessary for neutrophil engraftment to occur...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.